Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Fish oil in comparison to folinic acid for protection against adverse effects of methotrexate chemotherapy on bone.

Raghu Nadhanan R, Fan CM, Su YW, Howe PR, Xian CJ.

J Orthop Res. 2014 Apr;32(4):587-96. doi: 10.1002/jor.22565.

2.

Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats.

Raghu Nadhanan R, Skinner J, Chung R, Su YW, Howe PR, Xian CJ.

PLoS One. 2013 Aug 12;8(8):e71592. doi: 10.1371/journal.pone.0071592.

3.
4.

Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.

Fan C, Cool JC, Scherer MA, Foster BK, Shandala T, Tapp H, Xian CJ.

Bone. 2009 Jan;44(1):61-70. doi: 10.1016/j.bone.2008.09.014.

PMID:
18976724
5.

Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells.

Xian CJ, Cool JC, Scherer MA, Fan C, Foster BK.

J Cell Physiol. 2008 Mar;214(3):777-85.

PMID:
17786974
6.

Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.

King TJ, Shandala T, Lee AM, Foster BK, Chen KM, Howe PR, Xian CJ.

Int J Mol Sci. 2015 Aug 6;16(8):18293-311. doi: 10.3390/ijms160818293.

7.

Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.

Georgiou KR, Scherer MA, Fan CM, Cool JC, King TJ, Foster BK, Xian CJ.

J Cell Physiol. 2012 Mar;227(3):909-18. doi: 10.1002/jcp.22807.

PMID:
21503894
8.

Methotrexate-induced bone marrow adiposity is mitigated by folinic acid supplementation through the regulation of Wnt/β-catenin signalling.

Georgiou KR, Nadhanan RR, Fan CM, Xian CJ.

J Cell Physiol. 2015 Mar;230(3):648-56. doi: 10.1002/jcp.24788.

PMID:
25187349
9.

Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.

Georgiou KR, King TJ, Scherer MA, Zhou H, Foster BK, Xian CJ.

Bone. 2012 Jun;50(6):1223-33. doi: 10.1016/j.bone.2012.03.027.

PMID:
22484100
10.

Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss.

Raghu Nadhanan R, Abimosleh SM, Su YW, Scherer MA, Howarth GS, Xian CJ.

Am J Physiol Endocrinol Metab. 2012 Jun 1;302(11):E1440-9. doi: 10.1152/ajpendo.00587.2011.

11.

Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.

Xian CJ, Cool JC, Scherer MA, Macsai CE, Fan C, Covino M, Foster BK.

Bone. 2007 Nov;41(5):842-50.

PMID:
17884747
12.

Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation.

King TJ, Georgiou KR, Cool JC, Scherer MA, Ang ES, Foster BK, Xu J, Xian CJ.

Am J Pathol. 2012 Jul;181(1):121-9. doi: 10.1016/j.ajpath.2012.03.037.

PMID:
22642908
13.

Protective effect of folinic acid on low-dose methotrexate genotoxicity.

Shahin AA, Ismail MM, Saleh AM, Moustafa HA, Aboul-Ella AA, Gabr HM.

Z Rheumatol. 2001 Apr;60(2):63-8.

PMID:
11383050
14.

Effect of methotrexate and folinic acid on skeletal growth in mice.

Iqbal MP, Ahmed M, Umer M, Mehboobali N, Qureshi AA.

Acta Paediatr. 2003 Dec;92(12):1438-44.

PMID:
14971796
15.

Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX).

Cohen IJ.

Med Hypotheses. 2013 Nov;81(5):942-7. doi: 10.1016/j.mehy.2013.08.027. Review.

PMID:
24035689
16.

Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.

Fan C, Georgiou KR, King TJ, Xian CJ.

J Biomed Biotechnol. 2011;2011:903097. doi: 10.1155/2011/903097. Review.

17.

Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.

Kang WD, Choi HS, Kim SM.

Gynecol Oncol. 2010 Jun;117(3):477-80. doi: 10.1016/j.ygyno.2010.02.029.

PMID:
20347479
18.

Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells.

Keshava C, Keshava N, Whong WZ, Nath J, Ong TM.

Mutat Res. 1998 Feb 2;397(2):221-8.

PMID:
9541646
19.

Folinic acid protects against suppression of growth by methotrexate in mice.

Iqbal MP, Sultana F, Mehboobali N, Pervez S.

Biopharm Drug Dispos. 2001 May;22(4):169-78.

PMID:
11745919
20.

Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.

Polyzos A, Tsavaris N, Giannopoulos A, Bacoyiannis C, Papadimas V, Kalahanis N, Karatzas G, Kosmas C, Sakelaropoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P.

Cancer Chemother Pharmacol. 1996;38(3):292-7.

PMID:
8646806
Items per page

Supplemental Content

Support Center